Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014
- PMID: 28161421
- DOI: 10.1016/j.vaccine.2017.01.034
Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014
Abstract
Background: China's Expanded Program on Immunization (EPI) has provided 4 doses of oral poliovirus vaccine (OPV) since the 1970s. Inactivated poliovirus vaccine (IPV) became available in 2010 in Hangzhou as a private-sector, parent-chosen alternative to OPV. In 2015, WHO recommended that countries with all-OPV vaccination schedules introduce at least one dose of IPV, to mitigate risk associated with the withdrawal of type 2 OPV. We analyzed polio vaccine coverage and utilization in Hangzhou to determine patterns of IPV use and the occurrence of vaccine-associated paralytic polio (VAPP) in the various patterns identified.
Methods: Children born between 2010 and 2014 and registered in Hangzhou's Immunization Information System (HZIIS) were included. VAPP cases were detected through the acute flaccid paralysis surveillance system. We used descriptive epidemiological methods to determine IPV and OPV usage patterns and VAPP occurrence.
Results: HZIIS data from 566,894 children were analyzed. Coverage levels of polio vaccine were greater than 92% for each birth cohort. Percentages of children using OPV-only, IPV-only, and IPV/OPV sequential schedules were 70.57%, 27.01% and 2.41%, respectively. IPV-only schedule utilization increased by birth cohort regardless of geographical area or whether the child was locally-born. The highest use of an all-IPV schedule (79.85%) was among urban, locally-born children in the 2014 birth cohort. Five VAPP cases were identified during the study years; all cases occurred following the first polio vaccine dose, which was always OPV for the cases. Type 2 vaccine virus was isolated from 2 VAPP cases, and type 2 and type 3 vaccine virus was isolated from one VAPP case. The incidence of VAPP in the 2010-2014 birth cohorts was 3.76 per 1million doses of OPV.
Conclusion: Children in Hangzhou had high polio vaccination coverage. IPV-only schedule use increased by year, and was highest in urban areas among locally-born children. All cases of VAPP were associated with the first dose of OPV.
Keywords: Poliovirus vaccine; VAPP; Vaccination.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2. Cochrane Database Syst Rev. 2019. PMID: 31801180 Free PMC article.
-
Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.MMWR Morb Mortal Wkly Rep. 2017 Dec 15;66(49):1357-1361. doi: 10.15585/mmwr.mm6649a4. MMWR Morb Mortal Wkly Rep. 2017. PMID: 29240729 Free PMC article.
-
Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.Hum Vaccin Immunother. 2016 Nov;12(11):2749-2752. doi: 10.1080/21645515.2016.1208327. Epub 2016 Jul 20. Hum Vaccin Immunother. 2016. PMID: 27437792 Free PMC article.
-
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.Pediatrics. 2001 May;107(5):E83. doi: 10.1542/peds.107.5.e83. Pediatrics. 2001. PMID: 11331733
-
Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.Pediatr Clin North Am. 2000 Apr;47(2):287-308. doi: 10.1016/s0031-3955(05)70208-x. Pediatr Clin North Am. 2000. PMID: 10761505 Review.
Cited by
-
Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China.BMC Infect Dis. 2020 Apr 7;20(1):271. doi: 10.1186/s12879-020-04992-x. BMC Infect Dis. 2020. PMID: 32264839 Free PMC article.
-
Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains.Hum Vaccin Immunother. 2020 Aug 2;16(8):1866-1874. doi: 10.1080/21645515.2019.1709352. Epub 2020 Mar 2. Hum Vaccin Immunother. 2020. PMID: 32118517 Free PMC article.
-
Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China.Front Public Health. 2022 Sep 23;10:990042. doi: 10.3389/fpubh.2022.990042. eCollection 2022. Front Public Health. 2022. PMID: 36211670 Free PMC article.
-
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2. Cochrane Database Syst Rev. 2019. PMID: 31801180 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical